Toronto, Canada

Molly B Schmid

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Affinium Pharmaceuticals, Inc.. Active years: 2009-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Molly B Schmid. Retrieved from https://idiyas.com/inventor/molly-b-schmid-5zxvhjey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Molly B Schmid

Introduction

Molly B Schmid is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that incorporate multiple bioactive agents. With a total of 2 patents to her name, her work is paving the way for advancements in antibacterial treatments.

Latest Patents

Molly's latest patents include innovative compositions that feature a FabI inhibitor alongside at least one other bioactive agent. This invention aims to enhance the effectiveness of antibacterial compositions by combining various agents to combat pathogenic bacteria. Additionally, her research has led to the identification of novel drug targets for these bacteria, providing purified proteins derived from specific amino acid sequences. These advancements are crucial for developing new therapeutic strategies against bacterial infections.

Career Highlights

Molly B Schmid is currently associated with Affinium Pharmaceuticals, Inc., where she continues to push the boundaries of pharmaceutical research. Her work is characterized by a commitment to improving health outcomes through innovative drug development.

Collaborations

Molly has collaborated with esteemed colleagues such as Judd Berman and John D Mendlein, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Molly B Schmid's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in addressing critical health challenges. Her patents and ongoing research are vital for the future of antibacterial therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…